Their popularity is also outpacing the rate of research, which means even scientists don't yet have all the answers when it comes to their long-term effects and who should be using them
Your symptoms are showing a downward trend over the first 14 days
Almost four years after my spinal cord injury and series of accidental discoveries along the way that evolved into my personal healing protocol, I have made a complete full recovery from cauda equina syndrome, and I've managed to get my PCOS symptoms under control and my pre-diabetes into remission
However, keep in mind this study didnt account for other important factors, such as patient compliance with the regimen, other medications perhaps the patient was taking that could affect this
When LDN Alone May Not Be Enough Some patients may experience suboptimal results with LDN alone, due to: Persistent metabolic dysregulation (like insulin resistance) Chronic inflammatory states resistant to LDNs immunomodulatory effects Co-existing conditions such as mild cognitive impairment or mood disorders Limitations with existing medications (like tramadol or other opiates) that excludes from LDN therapy, but not Microdosing GLP-1 In these cases, adding Microdosing GLP-1 may enhance outcomes by addressing metabolic and systemic inflammation more comprehensively
